August 23, 2014 12:12 AM ET

Biotechnology

Company Overview of Albireo AB

Company Overview

Albireo AB, a biotechnology company, focuses on the development of therapeutic drugs for gastrointestinal diseases. It develops A3309, an oral compound for the treatment of patients with chronic idiopathic constipation. The company also develops A4250, a hepatology candidate for the treatment of primary biliary cirrhosis, progressive familial intrahepatic cholestasis, and alagille syndrome. Albireo AB was founded in 2008 and is based in Gothenburg, Sweden.

Arvid Wallgrens Backe 20

Gothenburg,  413 46

Sweden

Founded in 2008

Phone:

46 3 17 41 14 80

Fax:

46 31 82 02 23

Key Executives for Albireo AB

Director of Finance & Operations
Chief Operating Officer and Director
Chief Medical Officer
Vice President of Development
Vice President of Pre-Clinical
Compensation as of Fiscal Year 2014.

Albireo AB Key Developments

Albireo AB Presents at BIO-Europe 2012, Nov-12-2012

Albireo AB Presents at BIO-Europe 2012, Nov-12-2012 . Venue: CCH Congress Center Hamburg, Am Dammtor / Marseiller Str, 20355 Hamburg, Germany.

Albireo AB Grants Orphan Drug Designation for A4250 from the US FDA

Albireo AB announced that A4250 (an inhibitor of the ileal bile acid transporter, IBAT/ASBT) has been granted orphan-drug designation by the U.S Food and Drug Administration (FDA) for the treatment of Progressive Familial Intrahepatic Cholestasis (PFIC) and Primary Biliary Cirrhosis (PBC). A4250 is an inhibitor of the bile acid transport mechanism and will decrease the toxic levels of bile acids in the liver cells.

Similar Private Companies By Industry

Company Name Region
Vitrolife Sweden AB Europe
Simplexia Europe
Lundonia Biotech AB Europe
Berolina Drug Development AB Europe
NovaHep AB Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Albireo AB, please visit www.albireopharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.